SP

Savita Pandey

Active Director Director DIN 09639420
DIN 09639420 First appointment Jun 2022 Primary industry Chemicals
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2022
Shareholding value β€’β€’β€’β€’ Premium profile

About Savita Pandey

Data last updated:

Savita Pandey is a Director at Must Cure Pharma Private Limited (since 2022). The company operates in Chemicals.

DIN 09639420
Primary Designation Director
Industry Chemicals
First Appointment 15 Jun 2022
Oldest Company Age 4 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Must Cure Pharma Private Limited U24239MP2022PTC061346
Director15 Jun 20222022Active

Board colleagues of Savita Pandey

NameDINCompanyDesignation
Santosh Kumar Shrivastava09639419Must Cure Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Must Cure Pharma Private Limited
Premium access

Shareholding and investment profile for Savita Pandey

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Savita Pandey

Savita Pandey currently holds 1 directorship: Must Cure Pharma Private Limited (Director, since 15 Jun 2022).

Savita Pandey was first appointed on 15 Jun 2022 as Director at Must Cure Pharma Private Limited.

The current boards of Savita Pandey's companies include Santosh Kumar Shrivastava (Must Cure Pharma Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available